A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer

Lung cancer accounts for the highest number of cancer-related deaths worldwide. Early diagnosis significantly increases the disease-free survival rate and a large amount of effort has been expended in screening trials and the development of early molecular diagnostics. However, a gold standard diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Barh, Debmalya, Jain, Neha, Tiwari, Sandeep, Field, John K, Padin-Iruegas, Elena, Ruibal, Alvaro, López, Rafael, Herranz, Michel, Bhattacharya, Antaripa, Juneja, Lucky, Viero, Cedric, Silva, Artur, Miyoshi, Anderson, Kumar, Anil, Blum, Kenneth, Azevedo, Vasco, Ghosh, Preetam, Liloglou, Triantafillos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908344/
https://www.ncbi.nlm.nih.gov/pubmed/24564251
http://dx.doi.org/10.1186/1471-2164-14-S6-S5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908344/
https://www.ncbi.nlm.nih.gov/pubmed/24564251
http://dx.doi.org/10.1186/1471-2164-14-S6-S5

Ejemplares similares